Does Cardiac Resynchronization Therapy (CRT) improve electrocardiographic, functional, and clinical outcomes in Adult Congenital Heart Disease (ACHD) patients?
Cardiac resynchronization therapy (biventricular and conduction system pacing) is associated with significant electrocardiographic, functional, and clinical improvements in adult congenital heart disease.
CRT in ACHD is associated with significant improvements in electrocardiographic, functional, and clinical outcomes, including patients with a systemic right ventricle. Although most evidence pertains to BiV, early reports on CSP are encouraging. Prospective, phenotype-specific studies with standardized outcomes are needed to optimize patient selection and pacing strategies.
Zwaenepoel et al. (Thu,) studied this question.